We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account

GCP

Home » Topics » Clinical Trials » GCP
  • August 9, 2017

    FDA Warns Clinical Researcher for Enrolling Ineligible Subjects

    The FDA issued a warning letter to a Texas clinical researcher, claiming he deviated from his own investigational plan by enrolling ineligible trial subjects.
  • August 9, 2017

    Clinical Trials Questions; FDA Answers

    The FDA’s rules for clinical investigators cover a lot of ground, from how to avoid financial conflicts of interest, to delegating investigator authority to other members of the trial team, to hiring—and sometimes firing—investigators under your charge. The FDA provides all the GCP regulations and guidances you need to run a clinical trial, but even those documents can’t answer every question you may have about the people who actually conduct the trial.
  • August 9, 2017

    FDA: Three-Parent Baby Technique in Clinical Research is Illegal

    The FDA ruled the use of mitochondrial replacement technology in clinical research is illegal.
Read More
  • April 10, 2017

    Clinical Trial Questions: FDA’s Answers

  • April 13, 2016

    Strategies to Reduce Inefficiency of GCP Training

  • January 21, 2016

    Report: Tweaking Clinical Trial Protocols Takes Toll on Research

  • January 15, 2016

    How Diverse Are Clinical Trials?

  • January 15, 2016

    Report Outlines Risk Factors for Low Enrollment In Cancer Trials

  • January 14, 2016

    Tufts Report Shines Light on Continued Use, Cost of Clinical Trial Protocol Changes

  • January 7, 2016

    Report: One-Fifth of Cancer Clinical Trials Fall Short on Recruitment Goals

  • December 31, 2015

    Risk Factors for Low Enrollment in Cancer Trials Spelled Out

  • December 14, 2015

    EMA Cracks Down on Noncompliant Trials

  • December 14, 2015

    New Project Hopes to Guide Ethical Use of Mobile Devices in Research

Read More

Products

  • Managing data and documentation for fda inspections and remote assessments 500

    Managing Data and Documentation for FDA Inspections and Remote Assessments

    $225.00
  • Califfs fda 2023 600red

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis – Webinar Recording/Transcript

    $337.00
  • International standards for clinical trials 500

    International Standards for Clinical Trials: Manual of ICH Efficacy Guidelines

    $249.00
  • Kara stockett quinn 500aqua

    The Inextricable Link Between Data Integrity and Quality Culture – Webinar Recording/Transcript

    $287.00
More Products

Events

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing